TrialAnnals of the rheumatic diseases2007

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.

Hilary A Capell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.